GlassScriptPhysician profile
Rami Al-Rashed
NPI 1255740494
$914.57
in general payments reported to CMS, 2019-2025
16 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $67.86 · 2021: $236 · 2024: $104 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $157.31 | 2020-2021 | |
| Allergan, INC. | $125.00 | 2019 | |
| Kci USA, INC. | $121.43 | 2019 | |
| Bioventus LLC | $107.54 | 2019 | |
| Organogenesis INC. | $103.68 | 2020-2025 | Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $81.27 | 2021-2024 | Nuzyra |
| Biotissue Holdings INC. | $55.25 | 2025 | |
| Omeza LLC | $22.93 | 2024 | |
| Amgen INC. | $22.31 | 2025 | Krystexxa |
| Orthofix Medical, INC. | $21.38 | 2020-2021 | |
| Mimedx Group, INC. | $20.22 | 2025 | |
| Integra Lifesciences Corporation | $19.31 | 2019 | |
| Averitas Pharma INC. | $15.35 | 2024 | Qutenza |
| Alfasigma USA, INC. | $15.33 | 2020 | |
| Trice Medical, INC. | $14.15 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rami Al-Rashed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.